Anzeige
Mehr »
Dienstag, 12.08.2025 - Börsentäglich über 12.000 News
Diese Aktie liegt in der Turbo-Zone - und könnte der Gold-Gewinner 2025/26 werden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Private Equity Wire

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
04.08.HIG nabs Morgan Stanley Execs
04.08.Advent tops KKR with sweetened $6.4bn Spectris offer
04.08.Silversmith secures $1.7bn for fifth buyout fund
01.08.Montefiore, Ceres Industries, CFJ discuss Karavel Groupe acquisition
01.08.Carlyle anchors AUD600M preferred equity for Insignia buyout
01.08.Keensight Capital to partner with UVE Solutions
01.08.KKR and Capital Group to launch fund blending public and private equity
01.08.Grant Thornton appoints Private Equity practice lead
01.08.Vista eyes $200m saving from private credit pivot
01.08.KKR, Carlyle, and EQT on shortlist for Starbucks China Investment
01.08.BC Partners facing management revolt at portfolio company United Group
31.07.Thoma Bravo bolsters private credit platform with senior hires from Morgan Stanley
31.07.Skyline Investors closes $125m fund to support micro-market companies
31.07.GTCR to acquire FMG Suite from Aurora Capital Partners
31.07.Fifth Third, Eldridge form private credit partnership
31.07.Blue Point-backed NSA acquires Bashlin Industries
31.07.Hong Kong family office VMS Group pivots from private equity amid liquidity demands
31.07.KKR raises $6.5bn for second ABF fund
31.07.New Mountain nears deal for 40% Wiplfi stake at $1bn+ valuation
30.07.Astorg-backed Lebronze alloys acquires M LEGO
30.07.CalPERS maintains very strong conviction in PE amid exit slowdown
30.07.Anthropic reportedly nearing $5bn fundraise at $170bn valuation amid surging revenue
30.07.Peak Rock sells Shipley Do-Nuts to LLCP
30.07.Odyssey targets $1bn continuation fund to extend Industrial Electric hold
30.07.Bain Capital, Bristol Myers Squibb launch $300m immunology venture